Holen Sie sich die Stockscreener-App
15.06
5.93%
-0.95
Finanzdaten der Aktis Oncology Inc-Aktie (AKTS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
4.87%
3.384
|
3.227 | 9.027 | 5.855 | 7.51 |
| Operating Expenses |
24.49%
32.28
|
25.93 | 9.638 | 50.07 | 22.96 |
| Operating Income/Loss |
27.27%
-28.90
|
-22.71 | -5.336 | -50.70 | -22.61 |
| Nonoperating Income/Loss |
8.54%
4.755
|
4.381 | -1.083 | -58.10 | -0.698 |
Net Income/Loss
|
31.75%
-24.14
|
-18.32 | -6.42 | -108.80 | -23.31 |
| Basic Average Shares |
13.72%
55.30
|
48.63 | 154.43 | 10.24 | 91.28 |
| Diluted Average Shares |
13.72%
55.30
|
48.63 | 154.43 | 10.24 | 91.28 |
| Basic Earnings Per Share |
15.79%
-0.44
|
-0.38 | -0.04 | -1.14 | -0.26 |
| Diluted Earnings Per Share |
15.79%
-0.44
|
-0.38 | -0.04 | -1.14 | -0.26 |
1.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):